Literature DB >> 25819311

Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.

Choon Jin Ooi1, Govind K Makharia2, Ida Hilmi3, Peter R Gibson4, Kwong Ming Fock5, Vineet Ahuja2, Khoon Lin Ling1, Wee Chian Lim6, Kelvin T Thia1, Shu-chen Wei7, Wai Keung Leung8, Poh Koon Koh9, Richard B Gearry10, Khean Lee Goh3, Qin Ouyang11, Jose Sollano12, Sathaporn Manatsathit13, H Janaka de Silva14, Rungsun Rerknimitr15, Pises Pisespongsa16, Muhamad Radzi Abu Hassan17, Joseph Sung18, Toshifumi Hibi19, Christopher C M Boey20, Neil Moran21, Rupert W L Leong21.   

Abstract

The Asia Pacific Working Group on Inflammatory Bowel Disease was established in Cebu, Philippines, at the Asia Pacific Digestive Week conference in 2006 under the auspices of the Asian Pacific Association of Gastroenterology (APAGE) with the goal of developing best management practices, coordinating research and raising awareness of IBD in the region. The consensus group previously published recommendations for the diagnosis and management of ulcerative colitis (UC) with specific relevance to the Asia-Pacific region. The present consensus statements were developed following a similar process to address the epidemiology, diagnosis and management of Crohn's disease (CD). The goals of these statements are to pool the pertinent literature specifically highlighting relevant data and conditions in the Asia-Pacific region relating to the economy, health systems, background infectious diseases, differential diagnoses and treatment availability. It does not intend to be all-comprehensive and future revisions are likely to be required in this ever-changing field.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Crohn; IBD; consensus; definition; diagnosis; epidemiology; gastroenterology; guidelines; incidence; investigation

Mesh:

Year:  2016        PMID: 25819311     DOI: 10.1111/jgh.12958

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  19 in total

1.  Therapeutic Efficacy and Adverse Events of Tacrolimus in Patients with Crohn's Disease: Systematic Review and Meta-Analysis.

Authors:  Tomoya Iida; Masanori Nojima; Hiroshi Nakase
Journal:  Dig Dis Sci       Date:  2019-04-13       Impact factor: 3.199

Review 2.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

3.  Large retroperitoneal abscess extended to the inferior right limb secondary to a perforated ileal Crohn's disease: the importance of the multidisciplinary approach.

Authors:  A Mascolino; G Scerrino; R Gullo; C Genova; G I Melfa; C Raspanti; T Fontana; N Falco; C Porrello; G Gulotta
Journal:  G Chir       Date:  2016 Jan-Feb

Review 4.  The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West?

Authors:  Rashid N S Lui; Siew C Ng
Journal:  Inflamm Intest Dis       Date:  2016-07-15

Review 5.  Vedolizumab in Inflammatory Bowel Disease: West versus East.

Authors:  Prasanta Debnath; Pravin M Rathi
Journal:  Inflamm Intest Dis       Date:  2021-01-27

6.  Intestinal changes associated with fluoride exposure in rats: Integrative morphological, proteomic and microbiome analyses.

Authors:  Aline Dionizio; Dawud Abduweli Uyghurturk; Carina Guimarães Souza Melo; Isabela Tomazini Sabino-Arias; Tamara Teodoro Araujo; Talita Mendes Silva Ventura; Juliana Vanessa Colombo Martins Perles; Jacqueline Nelisis Zanoni; Pamela Den Besten; Marília Afonso Rabelo Buzalaf
Journal:  Chemosphere       Date:  2021-01-11       Impact factor: 8.943

7.  Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease.

Authors:  Kai-Chun Wu; Zhi Hua Ran; Xiang Gao; Minhu Chen; Jie Zhong; Jian-Qiu Sheng; Michael A Kamm; Simon Travis; Kori Wallace; Nael M Mostafa; Marisa Shapiro; Yao Li; Roopal B Thakkar; Anne M Robinson
Journal:  Intest Res       Date:  2016-04-27

8.  Proteome analysis of the macroscopically affected colonic mucosa of Crohn's disease and intestinal tuberculosis.

Authors:  Lokesh A Rukmangadachar; Govind K Makharia; Asha Mishra; Prasenjit Das; Gururao Hariprasad; Alagiri Srinivasan; Siddhartha Datta Gupta; Vineet Ahuja; Subrat K Acharya
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

Review 9.  Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: Review of general recommendations.

Authors:  Jose María Huguet; Patricia Suárez; Luis Ferrer-Barceló; Lucía Ruiz; Ana Monzó; Ana Belén Durá; Javier Sempere
Journal:  World J Gastrointest Endosc       Date:  2017-06-16

Review 10.  Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Authors:  Shu-Chen Wei; Ting-An Chang; Te-Hsin Chao; Jinn-Shiun Chen; Jen-Wei Chou; Yenn-Hwei Chou; Chiao-Hsiung Chuang; Wen-Hung Hsu; Tien-Yu Huang; Tzu-Chi Hsu; Chun-Chi Lin; Hung-Hsin Lin; Jen-Kou Lin; Wei-Chen Lin; Yen-Hsuan Ni; Ming-Jium Shieh; I-Lun Shih; Chia-Tung Shun; Yuk-Ming Tsang; Cheng-Yi Wang; Horng-Yuan Wang; Meng-Tzu Weng; Deng-Chyang Wu; Wen-Chieh Wu; Hsu-Heng Yen; Jau-Min Wong
Journal:  Intest Res       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.